Answer to Question 1
Correct Answer: 4
Rationale 1: Headache, nasal stuffiness, and earache are not common adverse effects of Pulmozyme.
Rationale 2: Nausea, vomiting, and diarrhea are not common adverse effects of Pulmozyme.
Rationale 3: Epigastric pain, belching, and flatulence are not common adverseeffects of Pulmozyme.
Rationale 4: The most common adverse effects of Pulmozyme are chest pain, hoarseness, sore throat, and conjunctivitis.
Global Rationale: Dornase alfa (Pulmozyme), is an enzyme that was approved in 1993 for the management of thick bronchial secretions in patients with cystic fibrosis. Dornase alfa breaks down deoxyribonucleic acid (DNA) molecules in the mucus, causing it to become less viscous. It is administered by the oral inhalation route. Adverse effects include chest pain, conjunctivitis, hoarseness, and pharyngitis. The remaining adverse effects are not assocated with Pulmozyme.
Answer to Question 2
Correct Answer: 2
Rationale 1: Mucomyst does not cause tingling.
Rationale 2: Mucomyst smells like rotten eggs. The odor bothers some more than others.
Rationale 3: Mucomyst does not cause dizziness.
Rationale 4: Mucomyst does not trigger chest pain.
Global Rationale: Acetylcysteine has a very unpleasant odor and can cause nausea and vomiting. Local irritation and stickiness on the face are also noted. It does not cause tingling, dizziness, or chest pain.
The tone of the nurse-patient introduction sets the stage for the patient interview and patient care
Client position when assessing jugular vein distention.
A client is having an endoscopy performed by a physician who views the upper gastrointestinal intern
Client and therapist positioning for foot reflexology.
Survey and posture of client: Lateral view